Taking your breath away…one macrophage, at a time.

This space will highlight literature relating to lung macrophages with emphasis on their functions during infections, repair, disease (resistance, tolerance, promotion) and mechanisms that drive those functions. I will also highlight their potential for innate immune memory.



2025

9. Almanzar, Chiu and colleagues highlight the role of TRPV1+ sensory neurons in regulation of monocyte and neutrophil recruitment and contributions to host immunopathology during IAV infection via upregulation of ATF3 thereby controlling viral spread . [9/n]


8. Chia, DeGregori and colleagues report maladaptive consequences of a previous respiratory infection that awakens dormant cancer cells using two mouse models of metastasized breast cancer (that develop disseminated cancer cells) in the lungs via IL-6 and CD4+ T cells. [8/n]


7. Qui, Tang and colleagues show how Dectin-1 signaling induces Arginase-1 / TGF-β AND and promotes profibrotic AMs via the Raf1-dependent pathway, bypassing CARD9 signaling and mono-macrophage chemotactic recruitment. [7/n]

6. Hoagland and Franklin show that macrophage-derived oncostatin M (OSM) is indispensable for repairing the lung epithelial barrier, maintenance of homeostasis and proliferation of lung epithelial cells to overcome IFN-I-mediated imunopathology [6/n]

5. Using two elegant transgenic mouse models: NAM-DTR and IFNAR-CKO mice - Yeung, Damani-Yokota & Khanna et al show that NAMs mitigate SARS lethality via type 1 interferon signaling. IFNAR1 expression on NAMs functions by sensing of type 1 IFNS (IFNa/b) as well as a survival switch for maintenance and proliferation of NAMs for their immunoregulatory functions to induce disease tolerance [5/n]

4. Using a fibrosis model in young vs aged mice, Farhat and Knapp show that an aged bone marrow autonomously produced more profibrotic Mo-AMs, had a reduced availability of Tregs-derived IL-10 causing exacerbated lung fibrosis. Very cool study showing the contribution of aged hematopoietic system in disease outcomes during lung fibrosis that relies on the Treg:IL-10 axis leading to the fibrotic phenotype of Mo-AMs.

3. Using a comparative analyses of human and murine PASCs, Xiaoqin Wei and Jie Sun’s group at UVA report that sever COVID-19 causes disruption of peroxisomes (small membrane bound structures) in alveolar macrophages causing impaired lung repair, increased inflammation and chronic fibrosis.

2. Dou Yu and Shuo Wang show that subcutaneous BCG vaccination induces MHCII+ ILC1 via TLR2 signaling, activate CD4+ T cells to promote anti-flu protection and immune response. Another evidence of skin:lung axis study.

1. Nargis Khan and Maz Divangahi show that β-glucan reprograms hematopoietic stem cells (HSC) in the bone marrow to generate ‘regulatory’ neutrophils which are required for promoting disease tolerance and lung tissue integrity against IAV challenge.



2024

21. Rebecca Dodd and Tara Sutherland identify IL-13 as a modulator of the Hyaluronan (HA) matrix during lung challenge. Using Nippostrongylus brasiliensis (Nb) model, authors link IL‐13‐mediated HA regulation to tissue repair pathways.

20. Sina Bohnacker and Julia Esser-Von Bieren published a beautiful study about identifying key roles of heGDH in immune evasion, parasite chronicity, and tissue repair during helminth infections (Heligmosomoides polygyrus bakeri, Hpb).


Representative iF image for hegDh (green), cD64 (magenta), and DaPi (blue) in the small intestine from a mouse in-fected with Hpb (4 days). White arrows indicate colocalization of hegDh and macrophages in the surroundings of l4 larvae (dashed circle).

19. Nitschké and colleagues show that systemic or local blockade of Notch2 leads to an increase in pro-fibrotic lung macs.. affecting only recruited macs. RTMs do not seem to be the drivers of fibrosis!

18. Yoon, Hwang and Ryu use a combination of antibody based neutralization techniques in OVA-induced asthma model, to show that CD39+ CD9+ interstitial macrophages (IMs) negatively regulate the neutrophilic inflammation during asthma by suppressing NETosis and provide a potential therapeutic target for the IL-23::Th17 axis.